Adjuvant (post‐surgery) chemotherapy for early stage epithelial ovarian cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Adjuvant (post‐surgery) Chemotherapy for Early Stage Epithelial Ovarian Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437788/all/Adjuvant__post‐surgery__chemotherapy_for_early_stage_epithelial_ovarian_cancer.
Adjuvant (post‐surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437788/all/Adjuvant__post‐surgery__chemotherapy_for_early_stage_epithelial_ovarian_cancer. Accessed March 15, 2025.
Adjuvant (post‐surgery) chemotherapy for early stage epithelial ovarian cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437788/all/Adjuvant__post‐surgery__chemotherapy_for_early_stage_epithelial_ovarian_cancer
Adjuvant (post‐surgery) Chemotherapy for Early Stage Epithelial Ovarian Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437788/all/Adjuvant__post‐surgery__chemotherapy_for_early_stage_epithelial_ovarian_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Adjuvant (post‐surgery) chemotherapy for early stage epithelial ovarian cancer
ID - 437788
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437788/all/Adjuvant__post‐surgery__chemotherapy_for_early_stage_epithelial_ovarian_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -